Biologics: Targets and Therapy
Country
New Zealand
Pacific Region
Subject Area and Category
Medicine
└
Gastroenterology
Q1
└
Pharmacology (medical)
Q1
└
Immunology and Allergy
Q2
Publisher
SJR 2025
0.989
Q1
SJR Score
H-Index
53
Citations / Doc (2yr)
4.37
Total Docs. (latest)
56
Total Citations (3yr)
318
Publication type
Journals
ISSN
11775491, 11775475
Coverage
1988, 2007-2026
Journal Rank
#4,981
Subject Categories
Gastroenterology
Q1
Pharmacology (medical)
Q1
Immunology and Allergy
Q2
Oncology
Q2
Rheumatology
Q2
Subject Areas
Aims & Scope
An international, peer-reviewed journal focusing on the patho-physiological rationale for and clinical application of Biologic agents in the management of autoimmune diseases, cancers or other pathologies where a molecular target can be identified.
Abstracting & Indexing
Scopus
Google Scholar
Directory of Open Access Journals (DOAJ)
Web of Science
Embase
Detailed Metrics
| Total Docs. (latest) | 56 |
| Total Docs. (3 years) | 69 |
| Total Refs. | 3,108 |
| Total Citations (3 years) | 318 |
| Citable Docs. (3 years) | 64 |
| Citations / Doc. (2 years) | 4.37 |
| Ref. / Doc. | 55.50 |
| % Female | 51.5% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Frequently Asked Questions
What is the impact factor of Biologics: Targets and Therapy?
The official Journal Impact Factor (JIF) is published by Clarivate in the Journal Citation Reports (JCR) and is not listed on this page. Based on SCImago data, Biologics: Targets and Therapy has an SJR of 0.989 and is ranked Q1.
What is the SJR and quartile of Biologics: Targets and Therapy?
Biologics: Targets and Therapy has an SJR (SCImago Journal Rank) of 0.989 and its best quartile is Q1.
What is the H-index of Biologics: Targets and Therapy?
The H-index of Biologics: Targets and Therapy is 53, meaning 53 of its articles have each been cited at least 53 times.
Is Biologics: Targets and Therapy indexed in Scopus?
Yes. Biologics: Targets and Therapy is active in Scopus (Scopus Source List, August 2026).
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.